Literature DB >> 23034908

A common polymorphism near PER1 and the timing of human behavioral rhythms.

Andrew S P Lim1, Anne-Marie Chang, Joshua M Shulman, Towfique Raj, Lori B Chibnik, Sean W Cain, Katherine Rothamel, Christophe Benoist, Amanda J Myers, Charles A Czeisler, Aron S Buchman, David A Bennett, Jeanne F Duffy, Clifford B Saper, Philip L De Jager.   

Abstract

OBJECTIVE: Circadian rhythms influence the timing of behavior, neurological diseases, and even death. Rare mutations in homologs of evolutionarily conserved clock genes are found in select pedigrees with extreme sleep timing, and there is suggestive evidence that certain common polymorphisms may be associated with self-reported day/night preference. However, no common polymorphism has been associated with the timing of directly observed human behavioral rhythms or other physiological markers of circadian timing at the population level.
METHODS: We performed a candidate gene association study with replication, evaluating associations between polymorphisms in homologs of evolutionarily conserved clock genes and the timing of behavioral rhythms measured by actigraphy. For validated polymorphisms, we evaluated associations with transcript expression and time of death in additional cohorts.
RESULTS: rs7221412, a common polymorphism near period homolog 1 (PER1), was associated with the timing of activity rhythms in both the discovery and replication cohorts (joint p = 2.1 × 10(-7) ). Mean activity timing was delayed by 67 minutes in rs7221412(GG) versus rs7221412(AA) homozygotes. rs7221412 also showed a suggestive time-dependent relationship with both cerebral cortex (p = 0.05) and CD14+ CD16- monocyte (p = 0.02) PER1 expression and an interesting association with time of death (p = 0.015) in which rs7221412(GG) individuals had a mean time of death nearly 7 hours later than rs7221412(AA/AG) .
INTERPRETATION: A common polymorphism near PER1 is associated with the timing of human behavioral rhythms, and shows evidence of association with time of death. This may be mediated by differential PER1 expression. These results may facilitate individualized scheduling of shift work, medical treatments, or monitoring of vulnerable patient populations.
Copyright © 2012 American Neurological Association.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23034908      PMCID: PMC3464954          DOI: 10.1002/ana.23636

Source DB:  PubMed          Journal:  Ann Neurol        ISSN: 0364-5134            Impact factor:   10.422


  39 in total

1.  Circadian variability in hemorrhagic stroke.

Authors:  Ilaria Casetta; Enrico Granieri; Francesco Portaluppi; Roberto Manfredini
Journal:  JAMA       Date:  2002-03-13       Impact factor: 56.272

2.  The 3111 Clock gene polymorphism is not associated with sleep and circadian rhythmicity in phenotypically characterized human subjects.

Authors:  Donna L Robilliard; Simon N Archer; Josephine Arendt; Steven W Lockley; Lisa M Hack; Judie English; Damien Leger; Marcel G Smits; Adrian Williams; Debra J Skene; Malcolm Von Schantz
Journal:  J Sleep Res       Date:  2002-12       Impact factor: 3.981

3.  An hPer2 phosphorylation site mutation in familial advanced sleep phase syndrome.

Authors:  K L Toh; C R Jones; Y He; E J Eide; W A Hinz; D M Virshup; L J Ptácek; Y H Fu
Journal:  Science       Date:  2001-02-09       Impact factor: 47.728

4.  Methods for cosinor-rhythmometry.

Authors:  W Nelson; Y L Tong; J K Lee; F Halberg
Journal:  Chronobiologia       Date:  1979 Oct-Dec

5.  Clock mutants of Drosophila melanogaster.

Authors:  R J Konopka; S Benzer
Journal:  Proc Natl Acad Sci U S A       Date:  1971-09       Impact factor: 11.205

6.  Total daily activity is associated with cognition in older persons.

Authors:  Aron S Buchman; Robert S Wilson; David A Bennett
Journal:  Am J Geriatr Psychiatry       Date:  2008-08       Impact factor: 4.105

7.  A length polymorphism in the circadian clock gene Per3 is linked to delayed sleep phase syndrome and extreme diurnal preference.

Authors:  Simon N Archer; Donna L Robilliard; Debra J Skene; Marcel Smits; Adrian Williams; Josephine Arendt; Malcolm von Schantz
Journal:  Sleep       Date:  2003-06-15       Impact factor: 5.849

Review 8.  Chronotherapy for cancer.

Authors:  M Eriguchi; F Levi; T Hisa; H Yanagie; Y Nonaka; Y Takeda
Journal:  Biomed Pharmacother       Date:  2003-10       Impact factor: 6.529

9.  Dementia severity and Lewy bodies affect circadian rhythms in Alzheimer disease.

Authors:  David G Harper; Edward G Stopa; Ann C McKee; Andrew Satlin; David Fish; Ladislav Volicer
Journal:  Neurobiol Aging       Date:  2004-07       Impact factor: 4.673

10.  PER3 polymorphism predicts sleep structure and waking performance.

Authors:  Antoine U Viola; Simon N Archer; Lynette M James; John A Groeger; June C Y Lo; Debra J Skene; Malcolm von Schantz; Derk-Jan Dijk
Journal:  Curr Biol       Date:  2007-03-08       Impact factor: 10.834

View more
  17 in total

1.  Pharmacokinetics of Irinotecan, Oxaliplatin and 5-Fluorouracil During Hepatic Artery Chronomodulated Infusion: A Translational European OPTILIV Study.

Authors:  Francis Lévi; Abdoulaye Karaboué; Marie-Christine Etienne-Grimaldi; Gilles Paintaud; Christian Focan; Pasquale Innominato; Mohamed Bouchahda; Gérard Milano; Etienne Chatelut
Journal:  Clin Pharmacokinet       Date:  2017-02       Impact factor: 6.447

2.  Neurodegeneration: amyloid awakenings.

Authors:  Moheb Costandi
Journal:  Nature       Date:  2013-05-23       Impact factor: 49.962

Review 3.  Dad's Snoring May Have Left Molecular Scars in Your DNA: the Emerging Role of Epigenetics in Sleep Disorders.

Authors:  Daniela Morales-Lara; Clelia De-la-Peña; Eric Murillo-Rodríguez
Journal:  Mol Neurobiol       Date:  2017-02-02       Impact factor: 5.590

4.  Circadian clock-related genetic risk scores and risk of placental abruption.

Authors:  Chunfang Qiu; Bizu Gelaye; Marie Denis; Mahlet G Tadesse; Miguel Angel Luque Fernandez; Daniel A Enquobahrie; Cande V Ananth; Sixto E Sanchez; Michelle A Williams
Journal:  Placenta       Date:  2015-10-23       Impact factor: 3.481

Review 5.  Building a pipeline to discover and validate novel therapeutic targets and lead compounds for Alzheimer's disease.

Authors:  David A Bennett; Lei Yu; Philip L De Jager
Journal:  Biochem Pharmacol       Date:  2014-02-06       Impact factor: 5.858

6.  Sex difference in daily rhythms of clock gene expression in the aged human cerebral cortex.

Authors:  Andrew S P Lim; Amanda J Myers; Lei Yu; Aron S Buchman; Jeanne F Duffy; Philip L De Jager; David A Bennett
Journal:  J Biol Rhythms       Date:  2013-04       Impact factor: 3.182

7.  The effect of melatonin on sleep and quality of life in patients with advanced breast cancer.

Authors:  Pasquale F Innominato; Andrew S Lim; Oxana Palesh; Mark Clemons; Maureen Trudeau; Andrea Eisen; Cathy Wang; Alex Kiss; Kathleen I Pritchard; Georg A Bjarnason
Journal:  Support Care Cancer       Date:  2015-08-11       Impact factor: 3.603

Review 8.  The significance of circadian rhythms and dysrhythmias in critical illness.

Authors:  Helen T McKenna; Irwin Km Reiss; Daniel S Martin
Journal:  J Intensive Care Soc       Date:  2017-02-13

9.  Circadian polymorphisms in night owls, in bipolars, and in non-24-hour sleep cycles.

Authors:  Daniel F Kripke; Walter T Klimecki; Caroline M Nievergelt; Katharine M Rex; Sarah S Murray; Tatyana Shekhtman; Gregory J Tranah; Richard T Loving; Heon-Jeong Lee; Min Kyu Rhee; Farhad F Shadan; J Steven Poceta; Shazia M Jamil; Lawrence E Kline; John R Kelsoe
Journal:  Psychiatry Investig       Date:  2014-10-20       Impact factor: 2.505

10.  24-hour rhythms of DNA methylation and their relation with rhythms of RNA expression in the human dorsolateral prefrontal cortex.

Authors:  Andrew S P Lim; Gyan P Srivastava; Lei Yu; Lori B Chibnik; Jishu Xu; Aron S Buchman; Julie A Schneider; Amanda J Myers; David A Bennett; Philip L De Jager
Journal:  PLoS Genet       Date:  2014-11-06       Impact factor: 5.917

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.